CH677795A5 - - Google Patents

Download PDF

Info

Publication number
CH677795A5
CH677795A5 CH1301/89A CH130189A CH677795A5 CH 677795 A5 CH677795 A5 CH 677795A5 CH 1301/89 A CH1301/89 A CH 1301/89A CH 130189 A CH130189 A CH 130189A CH 677795 A5 CH677795 A5 CH 677795A5
Authority
CH
Switzerland
Prior art keywords
hydrogen
formula
residue
alkyl
atoms
Prior art date
Application number
CH1301/89A
Other languages
German (de)
English (en)
Inventor
Rainer Dr Albert
Wilfried Bauer
Francois Dr Cardinaux
Janos Dr Pless
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808442A external-priority patent/GB8808442D0/en
Priority claimed from GB888826452A external-priority patent/GB8826452D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of CH677795A5 publication Critical patent/CH677795A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH1301/89A 1988-04-11 1989-04-07 CH677795A5 ( )

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808442A GB8808442D0 (en) 1988-04-11 1988-04-11 Peptide derivatives
GB888826452A GB8826452D0 (en) 1988-11-11 1988-11-11 Peptide derivatives

Publications (1)

Publication Number Publication Date
CH677795A5 true CH677795A5 ( ) 1991-06-28

Family

ID=26293760

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1301/89A CH677795A5 ( ) 1988-04-11 1989-04-07

Country Status (14)

Country Link
JP (1) JPH01305098A ( )
AU (1) AU3263989A ( )
BE (1) BE1003200A4 ( )
CH (1) CH677795A5 ( )
DE (1) DE3910667A1 ( )
DK (1) DK171489A ( )
ES (1) ES2013431A6 ( )
FR (1) FR2629824B1 ( )
GB (1) GB2224280B ( )
IL (1) IL89897A0 ( )
IT (1) IT1231943B ( )
LU (1) LU87496A1 ( )
NL (1) NL8900882A ( )
SE (1) SE8901278L ( )

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139526A (en) * 1977-12-01 1979-02-13 Merck & Co., Inc. Somatostatin analogs
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols

Also Published As

Publication number Publication date
IT8947833A0 (it) 1989-04-10
FR2629824B1 (fr) 1995-03-10
BE1003200A4 (fr) 1992-01-14
NL8900882A (nl) 1989-11-01
SE8901278D0 (sv) 1989-04-10
LU87496A1 (fr) 1989-11-14
DK171489A (da) 1989-10-12
IL89897A0 (en) 1989-12-15
FR2629824A1 (fr) 1989-10-13
ES2013431A6 (es) 1990-05-01
IT1231943B (it) 1992-01-16
JPH01305098A (ja) 1989-12-08
DK171489D0 (da) 1989-04-10
GB8907902D0 (en) 1989-05-24
GB2224280B (en) 1992-07-08
GB2224280A (en) 1990-05-02
AU3263989A (en) 1989-10-12
DE3910667A1 (de) 1989-10-19
SE8901278L (sv) 1989-10-12

Similar Documents

Publication Publication Date Title
AT403476B (de) Somatostatinpeptid
DE2514381C3 (de) Tripeptide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DD293832A5 (de) Lineare somatostatinanaloge
CH682632A5 (de) Mit Zuckerresten modifizierte Peptide.
DE3207311A1 (de) Neue n-acylpolypeptide und ihre herstellung
CH679045A5 ( )
DE2634416A1 (de) Peptide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2705514C3 (de) Nonapeptide und diese enthaltende Arzneimittel
CH615904A5 (en) Process for the preparation of L-leucine-13-motilin
CH649562A5 (de) Derivate des methionin-enzephalins.
DE69736193T2 (de) Somatostatin-antagonisten
CH683318A5 (de) Verwendung von Somatostatinpeptiden zur Herstellung pharmazeutischer Zusammensetzungen.
US4405607A (en) Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
DE3328952A1 (de) Neue polypeptide, verfahren zu ihrer herstellung, pharmazeutische praeparate welche sie enthalten, sowie ihre verwendung
EP0117447B1 (de) Cyclische Peptide mit Somatostatin-Wirkung
CH677795A5 ( )
EP0028716B1 (de) Motilitätssteigernde Peptide und deren Verwendung
CH618960A5 ( )
DE2628006C2 (de) Tridecapeptid, Verfahren zu seiner Herstellung und seine Verwendung
DE3333752A1 (de) Pharmakologisch aktive peptide
EP0095557B1 (de) Polypeptide mit antagonistischen Eigenschaften gegenüber der Substanz P, Verfahren zu ihrer Herstellung, deren Verwendung und Verfahren zum Reinigen von Polypeptiden
DE2628006C3 ( )
DE3820770A1 (de) Polypeptide
WO2004024755A2 (de) Sarcolysyl-derivate und verfahren zu deren herstellung
DE2721760A1 (de) Peptidderivate und verfahren zu deren herstellung

Legal Events

Date Code Title Description
PL Patent ceased